Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients.
Amelia HarrisonBrigitte BorgBruce ThompsonMark HewEli DabscheckPublished in: Internal medicine journal (2018)
The Australian National Chronic Obstructive Pulmonary Disease (COPD) guidelines recommend that inhaled corticosteroids (ICS) be reserved for patients with a post-bronchodilator forced expiratory volume in 1 s (FEV1 ) less than 50% predicted and those who experience ≥2 exacerbations in 12 months. In total, 707 COPD patients were identified from the lung function test database at our tertiary hospital; 52.4% of patients with a post-bronchodilator FEV1 ≥50% were prescribed an ICS. Significant discordance exists between guideline recommendations and inhaler prescription.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- cystic fibrosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- air pollution
- prognostic factors
- peritoneal dialysis
- clinical practice
- intensive care unit
- patient reported outcomes
- adverse drug
- electronic health record